| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.087 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |